Reuters logo
BRIEF-Akcea Therapeutics says MHRA has granted Volanesorsen a PIM designation
October 10, 2017 / 6:14 AM / 14 days ago

BRIEF-Akcea Therapeutics says MHRA has granted Volanesorsen a PIM designation

Oct 10 (Reuters) - Akcea Therapeutics:

* Akcea Therapeutics Inc says UK announced that Volanesorsen has been granted a PIM designation by MHRA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below